A Brief History of Pharmacopoeias: A Global Perspective (PDF)

Treatments for autoimmune diseases, multiple cancers, and skin blistering have been recommended for marketing approval.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Contractors are working with sponsor companies to establish and maintain sustainable manufacturing practices in pharma.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation by CHMP in December 2024.

Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.